ArticleJACC. Case reports2026
Transcatheter Aortic Valve Replacement in Patients With Interstitial Lung Disease: A Cautionary Tale.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPatients with interstitial lung disease (ILD) are at higher risk of complications with cardiac surgery than the general population, leading to interest in transcatheter technologies such as transcatheter aortic valve replacement (TAVR) as an alternative to surgery for this patient population. However, outcomes of TAVR in patients with ILD remain under assessment. CASE SUMMARY: We present 2 cases of mortality likely due to acute exacerbation of ILD following TAVR in patients with ILD who underwent TAVR. DISCUSSION: The risk of complications with TAVR is likely underrecognized in patients with ILD. TAKE-HOME MESSAGE: There is a need for better risk stratification among patients with ILD undergoing TAVR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.